FDA Approves Nivolumab + Ipilimumab for Certain CRC Patients ...Middle East

News by : (Medscape) -
The CRC indication is the latest approval for the combination therapy, which demonstrated improved PFS vs chemotherapy and nivolumab monotherapy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Nivolumab + Ipilimumab for Certain CRC Patients )

Also on site :

Most Viewed News
جديد الاخبار